U.S., Dec. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07259564) titled 'A Study of GS3-007a for Oral Suspension in the Diagnosis of Adult Growth Hormone Deficiency (AGHD)' on Nov. 13.
Brief Summary: The GS3-007a Growth Hormone Stimulation Test (GHST) will be compared with the Insulin Tolerance Test (ITT) in an open-label, randomized, three-way crossover trial. The trial will include subjects suspected to have adult growth hormone deficiency (AGHD) and a group of healthy control subjects.
Study Start Date: Dec. 19
Study Type: INTERVENTIONAL
Condition:
Adult Growth Hormone Deficiency (AGHD)
Intervention:
DRUG: GS3-007a dry suspension
GS3-007a dry suspension, low dose body weight, drinking solution, ...